| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/17/2003 | WO2003031654A1 Microarray comprising probes for mycobacteria species genotyping, m. tuberculosis strain differenciation, and antibiotic-resistant strain detection |
| 04/17/2003 | WO2003031653A1 METHOD OF SELECTING BARLEY VARIETY, BARLEY β-AMYLASE GENE AND PROCESS FOR PRODUCING MALT ALCOHOLIC DRINK |
| 04/17/2003 | WO2003031652A1 Method of examining type i diabetes |
| 04/17/2003 | WO2003031651A2 Method of determining susceptibility to inflammatory bowel disease |
| 04/17/2003 | WO2003031650A2 Genes and proteins for prevention, prediction, prognosis and therapy of cardiovascular disease |
| 04/17/2003 | WO2003031649A2 Method for the determination of cytosine methylation in cpg islands |
| 04/17/2003 | WO2003031648A2 Method for detecting dna methylation using labelled s-adenosylmethionine analogs |
| 04/17/2003 | WO2003031647A1 Automated genotyping |
| 04/17/2003 | WO2003031646A1 Multiple genetic marker selection and amplification |
| 04/17/2003 | WO2003031645A1 Preincubation assay method using single-stranded nucleic acid oligomer |
| 04/17/2003 | WO2003031644A2 Method for modelling hydrocarbon degradation in an oil deposit |
| 04/17/2003 | WO2003031641A2 Beta 2 adrenergic polymorphism detection |
| 04/17/2003 | WO2003031625A1 Esterase esta extracted from rhodococcus ruber |
| 04/17/2003 | WO2003031615A1 Lysophosphatidic acid synthase inhibitor |
| 04/17/2003 | WO2003031612A2 Method for determining cell cycle position |
| 04/17/2003 | WO2003031611A2 Phagemid display system |
| 04/17/2003 | WO2003031609A1 Esterase esta of rhodococcus sp. |
| 04/17/2003 | WO2003031608A2 Mutated abl kinase domains |
| 04/17/2003 | WO2003031604A1 Gastrointestinal chemosensory receptors |
| 04/17/2003 | WO2003031595A2 Molecules for disease detection and treatment |
| 04/17/2003 | WO2003031594A2 Nucleotide and amino acid sequences relating to respiratory diseases and obesity |
| 04/17/2003 | WO2003031592A2 Gene markers for beef marbling and tenderness |
| 04/17/2003 | WO2003031591A2 Detecting targets by unique identifier nucleotide tags |
| 04/17/2003 | WO2003031580A2 Methods and compositions for mutation analysis by liquid chromatography |
| 04/17/2003 | WO2003031579A2 Human tyrosine-dna phosphodiesterase variant polypeptides and methods of use therefor |
| 04/17/2003 | WO2003031573A2 Toll-like receptor 3 signaling agonists and antagonists |
| 04/17/2003 | WO2003031571A2 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 04/17/2003 | WO2003031568A2 Intracellular signaling molecules |
| 04/17/2003 | WO2003031567A2 Precursor conversion screening methods |
| 04/17/2003 | WO2003031563A1 Sensors for the detection of an analyte |
| 04/17/2003 | WO2003031561A1 Hybrid nucleic acid assembly |
| 04/17/2003 | WO2003031463A2 14081, a human trypsin-like serine protease family member and uses therefor |
| 04/17/2003 | WO2003031462A2 Nogo receptor-mediated blockade of axonal growth |
| 04/17/2003 | WO2003031063A2 Device for holding a substance library carrier |
| 04/17/2003 | WO2003031054A2 Arrays having clustered arrangements and methods of making and using them |
| 04/17/2003 | WO2003030924A1 Identification of specific modulators of bone formation |
| 04/17/2003 | WO2003030922A2 Bestrophin and bestrophin homologous proteins involved in the regulation of energy homeostasis |
| 04/17/2003 | WO2003030826A2 Antisense modulation of insulin-like growth factor binding protein 5 expression |
| 04/17/2003 | WO2003030725A2 Pancreatic cancer diagnosis and therapies |
| 04/17/2003 | WO2003030719A2 Methods and kits for use in selecting approaches to treating cancer |
| 04/17/2003 | WO2003030624A2 Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof |
| 04/17/2003 | WO2003030622A2 Detection and characterization of pyschoactives using analysis of network level physiological responses in a neuronal sample |
| 04/17/2003 | WO2003030616A2 21132, a human g-protein coupled receptor family member and uses therefor |
| 04/17/2003 | WO2003030612A2 Methods for modulating activity of the fxr nuclear receptor |
| 04/17/2003 | WO2003020950A3 Methods and compositions for bi-directional polymorphism detection |
| 04/17/2003 | WO2003004630A3 Method for determining the genetic predisposition of a mammal for its milk fat content and/or for its intramuscular fat content |
| 04/17/2003 | WO2002095071A3 Means and methods for identifying genes and proteins involved in the prevention and/or repair of a replication error |
| 04/17/2003 | WO2002094985A3 Beta-secretase substrates and uses thereof |
| 04/17/2003 | WO2002094863A3 INTERFERON-α INDUCED GENE |
| 04/17/2003 | WO2002086441A3 Amplification and detection of mycoplasma pneumoniae |
| 04/17/2003 | WO2002085943A3 Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof |
| 04/17/2003 | WO2002081735A3 Detection of negatively charged polymers using water-soluble, cationic, polythiophene derivatives |
| 04/17/2003 | WO2002076486A3 Histidine-rich glycoprotein |
| 04/17/2003 | WO2002070743A3 Identification and use of inhibitors of hair growth |
| 04/17/2003 | WO2002070706A3 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 04/17/2003 | WO2002064823A3 Method for detecting and/or quantifying an analyte |
| 04/17/2003 | WO2002061428A3 Method of disrupting interactions between biotin and biotin-binding compounds |
| 04/17/2003 | WO2002061070A3 Environmentally regulated genes, involved in the virulence of streptococcus suis |
| 04/17/2003 | WO2002052044A9 Detection of genetic polymorphisms in genes associated with pharmacogenomics |
| 04/17/2003 | WO2002050284A3 Oxidoreductases |
| 04/17/2003 | WO2002037109A3 Detection of binding species with colloidal and non-colloidal structures |
| 04/17/2003 | WO2002032960A3 Methods of selecting compounds for modulation of bladder function |
| 04/17/2003 | WO2002032291A9 Imaging of enzymatic activity |
| 04/17/2003 | WO2002029036A3 Lipid metabolism enzymes |
| 04/17/2003 | WO2002027327A3 Rapid profiling of the interactions between a chemical entity and proteins in a given proteome |
| 04/17/2003 | WO2002024891A3 B7-like molecules and uses thereof |
| 04/17/2003 | WO2002018576A3 Compositions and methods relating to lung specific genes |
| 04/17/2003 | WO2002018575A3 Genes expressed in the cell cycle |
| 04/17/2003 | WO2002014559A3 High throughput screen for inhibitors of the folate biosynthetic pathway in bacteria |
| 04/17/2003 | WO2002010437A3 Synthetic and recombinant substrates for the detection of the von willebrand factor-cleaving protease |
| 04/17/2003 | WO2002010402A3 Isolation of drosophila and human polynucleotides encoding par-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides |
| 04/17/2003 | WO2002006831A8 Method for establishing the effect of a substance on living cells |
| 04/17/2003 | WO2002006523A3 Method for detecting pre-disposition to hepatotoxicity |
| 04/17/2003 | WO2002004674A3 Transposon mediated multiplex sequencing |
| 04/17/2003 | WO2002004511A3 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS |
| 04/17/2003 | WO2001098366A3 Enterokinase cleavage sequences and their use |
| 04/17/2003 | WO2001096599A3 Methods for quantitative determination of b-fibronectin in biological fluids and tissues |
| 04/17/2003 | WO2001090413A3 Method and markers for prognosticating efficacy of anticancer agents |
| 04/17/2003 | WO2001072773A3 Genes isolated from dendritic cells, gene products and methods employing the same |
| 04/17/2003 | WO2001057275A3 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human brain |
| 04/17/2003 | WO2001046687A3 System and method for automated matched ion polynucleotide chromatography |
| 04/17/2003 | WO2001023621A3 Chromosome alterations in prostate cancer |
| 04/17/2003 | WO2001023608A3 Hybridization probes which specifically detect strains of the genera microbispora, microtetraspora, nonomuria and planobispora |
| 04/17/2003 | WO2001011082A3 Methods of gene expression monitoring |
| 04/17/2003 | US20030074698 Method for modifying plant morphology, biochemistry and physiology |
| 04/17/2003 | US20030074363 Method and system for providing a polymorphism database |
| 04/17/2003 | US20030073888 Screening methods used to identify compounds that modulate a response of a cell to ultraviolet radiation exposure |
| 04/17/2003 | US20030073866 Labeling nucleic acids with fluorescent complex of cyanine dye and carbodiimide compound |
| 04/17/2003 | US20030073827 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 04/17/2003 | US20030073819 PGC-1, a novel brown fat PPARgamma coactivator |
| 04/17/2003 | US20030073813 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030073809 Nucleotide sequence codin polypeptide for use in the diagnosis and treatment of nervous system and cancer disorders |
| 04/17/2003 | US20030073661 Method of modulating or examining Ku70 levels in cells |
| 04/17/2003 | US20030073635 Diagnosis and treatment of disorders of iron metabolism |
| 04/17/2003 | US20030073632 Controlling gene expression; apoptosis therapy |
| 04/17/2003 | US20030073624 Anticancer agents; isolated nucleic acids; genetic engineering |
| 04/17/2003 | US20030073623 Isolated polypeptide |
| 04/17/2003 | US20030073612 Calibrating polymorphism of human genome; therapy for skin disorders |
| 04/17/2003 | US20030073610 Prevention protein misfolding; central nervous system disorders; Alzheimer's, Parkinson's, Huntington's disease therapy |
| 04/17/2003 | US20030073250 Method and apparatus for solid state molecular analysis |